Eric discusses the initial promise of hydroxychloroquine during the SARS outbreak and its subsequent politicization. He highlights the impact of two retracted studies that falsely linked the drug to heart issues, revealing the corruption within high-impact medical journals. The conversation raises critical questions about the treatment options available and the need for transparent, evidence-based medicine.
